NCT02212769

the Pharmacokinetic Profiles of Losartan With DW1029M

A Randomized, Open-label, Multiple-dose, Crossover Phase I Clinical Study to Evaluate DW1029M Influence the Pharmacokinetic Profiles of Losartan After Oral Administration in Healthy Male Volunteer

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Dong Wha Pharmaceutical Co. Ltd. · Industry
• Sex: Male
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Phase I clinical study to evaluate DW1029M influence the pharmacokinetic profiles of Losartan after oral administration in healthy male volunteer

Detailed description

A Randomized, open-label, multiple-dose, crossover phase I clinical study to evaluate DW1029M influence the pharmacokinetic profiles of Losartan after oral administration in healthy male volunteer

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Losartan 50mg	Losartan 50mg once daily for 7 days
DRUG	DW1029M 1200mg and Losartan 50mg	Losartan 50mg 1 Tablet once daily and DW1029M 300mg 2 Tablets b.i.d. for 7days

Timeline

• Start date: 2014-08-01
• Primary completion: 2015-01-01
• Completion: 2015-02-01
• First posted: 2014-08-08
• Last updated: 2015-06-29

Locations

1 site across 1 country: South Korea